TTK HEALTHCARE LIMITED Intrinsic Value
TTKHLTCARE · Diversified · Current price ₹1,127.6
Is TTK HEALTHCARE LIMITED undervalued?
DocStoX estimates the fair value of TTK HEALTHCARE LIMITED at ₹804 per share, versus the current market price of ₹1,128. That puts the stock about -28.7% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is high.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹728), Relative P/E (₹900), Graham floor (₹906). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹684 (bear) to ₹804 (base) to ₹925 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹1,128 versus an intrinsic value of ₹804, TTK HEALTHCARE LIMITED currently offers -28.7% of negative margin (i.e. a premium).
More on TTK HEALTHCARE LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.